Logo image
Risk of merkel cell carcinoma after solid organ transplantation
Journal article   Open access   Peer reviewed

Risk of merkel cell carcinoma after solid organ transplantation

Christina A Clarke, Hilary A Robbins, Zaria Tatalovich, Charles F Lynch, Karen S Pawlish, Jack L Finch, Brenda Y Hernandez, Joseph F Fraumeni Jr, Margaret M Madeleine and Eric A Engels
JNCI : Journal of the National Cancer Institute, Vol.107(2), pp.dju382-dju382
02/2015
DOI: 10.1093/jnci/dju382
PMCID: PMC4311175
PMID: 25575645
url
https://doi.org/10.1093/jnci/dju382View
Published (Version of record) Open Access

Abstract

Solid organ transplant recipients have elevated risks of virus-related cancers, in part because of long-term immunosuppression. Merkel cell carcinoma (MCC) is an aggressive skin cancer recently found to have a viral origin, but little is known regarding the occurrence of MCC after transplant. We linked the US Scientific Registry of Transplant Recipients with data from 15 population-based cancer registries to ascertain MCC occurrence among 189498 solid organ transplant recipients from 1987 to 2009. Risks for MCC following transplantation were compared with the general population using standardized incidence ratios, and Poisson regression was used to compare incidence rates according to key patient and transplant characteristics. All statistical tests were two-sided. After solid organ transplantation, overall risk of MCC was increased 23.8-fold (95% confidence interval = 19.6 to 28.7, n = 110). Adjusted risks were highest among older recipients, increased with time since transplantation, and varied by organ type (all P ≤ .007). Azathioprine, cyclosporine, and mTOR inhibitors given for maintenance immunosuppression increased risk, and non-Hispanic white recipients on cyclosporine and azathioprine experienced increasing MCC risk with lower latitude of residence (ie, higher ultraviolet radiation exposure, P = .012). MCC risk is sharply elevated after solid organ transplant, likely resulting from long-term immunosuppression. Immunosuppressive medications may act synergistically with ultraviolet radiation to increase risk.
Organ Transplantation Registries United States - epidemiology Humans Middle Aged Male Photosensitizing Agents - adverse effects Carcinoma, Merkel Cell - etiology Transplant Recipients Incidence Photosensitizing Agents - administration & dosage TOR Serine-Threonine Kinases - antagonists & inhibitors Adult Female Remission Induction - methods Carcinoma, Merkel Cell - epidemiology Immunosuppressive Agents - administration & dosage Risk Assessment Risk Factors Skin Neoplasms - epidemiology Ultraviolet Rays - adverse effects Cyclosporine - adverse effects Immunosuppressive Agents - adverse effects Poisson Distribution Aged Skin Neoplasms - etiology Immunocompromised Host Azathioprine - adverse effects

Details

Metrics

Logo image